[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2
| SMILES |
None |
| InChIKey |
None |
| Sequence |
HSDAVFTNSYRKVLKRLSARKLLQDIL |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Molecular weight (Da) |
|
Database connections
|
|
| Ligand site mutations |
VPAC1
|
No bioactivity data available.
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
Database connections
|
|
| Ligand site mutations |
VPAC1
|
Compound is not listed as a drug.